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Objectives: Repeated, lowdose injections of Streptozo-
tocin (STZ) create amodel of Type II DiabetesMellitus. We
utilize thismodel to investigate the potential pro-repair effect
of syngeneic (equivalent to autologous) bone marrow-
derived mesenchymal stem cells (BMD-MSC) in Diabetes.
Methods: STZ (40 mg/Kg) was administered, daily,
for ﬁve days, i.p., in C57BL6 mice (N ¼ 12). Weekly blood
glucose levels (BG) were monitored by 2-hour Glucose
Tolerance Test (GTT) for ﬁve weeks after. Glucose intoler-
ance (150 < BG < 200 mg/dL) was used as the trigger for
treatment. The mice were then divided in two groups (N ¼
6/group). Control group received PBS and treatment
group received MSC (1x10
ˇ
6), by tail vein infusion. MSC
were obtained by culturing BMD cells from donor mice
(N ¼ 3) in MesenCult medium. b-cell activity was
measured by immunohistochemistry, and serum level of
insulin was assessed by C-peptide test.
Results: At baseline and post-STZ-induction, GTT
between control and treatment group did not differ
signiﬁcantly. However, at week 3 the MSC treatment
group’s GTT normalized and the effect is sustained by
week 5 (Fig). Control group continues to have signiﬁcant
glucose intolerance. Longer follow up is ongoing.
Conclusions: Systemic injection of a single MSC
treatment improves the Glucose Tolerance in a murine
model of Type II Diabetes. The ﬁndings will require
conﬁrmation in genetic murine models, yet depict a highly
promising novel concept for the treatment of Diabetes.
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Supplemental Oxygen Reverses Hypoxia Induced
Smooth Muscle Cell Proliferation by Modulating
HIF-alpha and VEGF Levels in a Rabbit
Arteriovenous Fistula ModelGreen1, Sabita Roy1, Steven Santilli1. 1Department of
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Objectives: Numerous mechanisms for the formation
of intimal hyperplasia have been proposed but none have
been proven or accepted. Our research focuses on the
potential role of Hypoxia Inducible Factors (HIFs),
VEGF, and PDGF as well as the ERK, PI3-K/AKT
pathway in hypoxia mediated intimal hyperplasia processes.
Methods: Rabbits were randomized into different
experimental groups with varying oxygen exposure and
receipt of surgery. Plasma samples were collected at desig-
nated intervals in which cytokines and smooth muscle cell
proliferation were measured. In addition, cell specimens
were exposed to hyperoxic, normoxic, and hypoxic envi-
ronments with cytokines measured at various time points.
Results: Placement of an arteriovenous ﬁstula resulted
in hypoxia induced HIF stabilization with a concurrent
increase in VEGF. Activation of VEGF receptors on smooth
muscle cells through ERK1 and AKT pathways resulted in
signiﬁcant smooth muscle cell proliferation and migration.
These effects are dramatically reduced in animals that are
exposed to a hyperoxic environment of 30% oxygen.
Conclusions: Our results suggest that short-term
administration of supplemental oxygen inhibits HIFs and
VEGF signaling to reduce smooth muscle proliferation in
the local blood vessel. These results provide strong support
for the therapeutic use of supplemental oxygen following
arterial surgery to reduce intimal hyperplasia. These ﬁnd-
ings also provide a nidus for future studies into the mech-
anisms of hypoxia induced intimal hyperplasia.
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Objectives: Contrast Induced Nephropathy (CIN) is
the third leading cause of hospital acquired renal failure,
which is a common complication following endovascular
surgery procedures. The mechanism of CIN is not fully
understood. Adenosine receptors (AR) regulate various
physiological activities in kidney. We hypothesized that
adenosine and its receptors may play a role in development
of CIN. The objectives of this study were to investigate the
expression changes of the four subtypes of adenosine recep-
tors (A1AR, A2AAR, A2BAR, and A3AR) following
administration of contrast agent in mice.
Methods: C57B1/6J mice were randomized to treat-
ment and control groups. Iodixanol, a commonly used
contrast agent, was administered to treatment groups
